Have you started noticing changes in your memory or ability to think clearly?
Have you started noticing changes in your memory or ability to think clearly?
If you are noticing changes in your memory or ability to think clearly, you may pre-qualify for a clinical research study for early symptomatic Alzheimer’s disease. This study will look at whether an investigational drug works and how safe it is in people with early symptomatic Alzheimer’s disease. The study will involve people who have memory loss that has gotten worse over time.
To see if you qualify, call Neurovations at 707-252-9606 or click on the link below to email us.
What is the cost?
All study related care will be provided at no cost to you. Health insurance is not required and your time and travel will be compensated.
In order to qualify, you must:
- Be 60 to 85 years old
- Have memory loss that has gotten worse over time
- Have a study partner who knows you and is willing to attend appointments with you throughout the study
How does it work?
For people with Alzheimer’s disease, an unwanted substance called “beta-amyloid” (or “β-amyloid”) builds up and forms plaques in the brain. It is believed that the build-up of β-amyloid plaques disrupts how brain cells function and leads to cell death. This study will examine whether an investigational drug, donanemab, can target and remove β-amyloid plaques. It is hoped that this can slow or stop the progress of Alzheimer’s by targeting and removing amyloid plaques.
To see if you qualify, call Neurovations at 707-252-9606 or click on the link below to email us.